Increased Local Failure for Patients with Intermediate-Risk Rhabdomyosarcoma on ARST0531: A Report from the Children’s Oncology Group

BACKGROUND: To evaluate local control for patients with intermediate-risk rhabdomyosarcoma (RMS) treated on Children’s Oncology Group (COG) protocol ARST0531. METHODS: We analyzed 424 patients with intermediate-risk RMS. Patients were randomized to chemotherapy with either vincristine, dactinomycin,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer
Hauptverfasser: Casey, Dana L., Chi, Yueh-Yun, Donaldson, Sarah S., Hawkins, Douglas S., Tian, Jing, Arndt, Carola A., Rodeberg, David A., Routh, Jonathan C., Lautz, Timothy B., Gupta, Abha A., Yock, Torunn I., Wolden, Suzanne L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6717036/
https://ncbi.nlm.nih.gov/pubmed/31174239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32204
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge